c-peptide

Peptideexperimental

The connecting peptide, or C-peptide, is a short 31-amino-acid polypeptide that connects insulin's A-chain to its B-chain in the proinsulin molecule. In the context of diabetes or hypoglycemia, a measurement of C-peptide blood serum levels can be used to distinguish between different conditions with similar clinical features. — Wikipedia

Clinical trial activity

6 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2003 (NCT00278980)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cbx129801
  • c-peptide
  • c-peptide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06427421N/AJun 30, 2024Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France
NCT06470295Early Phase 1 (Phase 1)Jun 1, 2024University of Cincinnati
NCT01681290Phase 2Oct 1, 2012Cebix Incorporated
NCT01665638Phase 1Sep 1, 2012Johnson and Johnson
NCT01293461Phase 1/Phase 2 (Phase 2)Apr 1, 2011Cebix Incorporated
NCT00278980Phase 2Oct 1, 2003Creative Peptides Sweden Inc., Karolinska Institute
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cebix IncorporatedFor profit2212011
Assistance Publique - Hôpitaux de ParisAcademic/Hospital1112024
Creative Peptides Sweden Inc.For profit1112003
Institut National de la Santé Et de la Recherche Médicale, FranceAcademic/Hospital1012024
Johnson and JohnsonFor profit1112012
Karolinska InstituteAcademic/Hospital1012003
University of CincinnatiAcademic/Hospital1112024
7 organizations
Page 1 / 1